Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

03/02/2025 03:00

Feb 3 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              374.56              389.90           485.00    
                   (-3.9 pct)          (+15.0 pct)      (-3.5 pct)  
  Operating           70.75              144.63            82.00    
                   (-51.1 pct)         (+18.0 pct)      (-48.7 pct) 
  Pretax              72.04              147.29            81.50    
                   (-51.1 pct)         (+18.4 pct)      (-50.2 pct) 
  Net                 56.59              110.54            58.00    
                   (-48.8 pct)         (+15.6 pct)      (-54.7 pct) 
  EPS Basic        120.49 yen          229.08 yen       123.49 yen  
  EPS Diluted      120.42 yen          229.06 yen                   
  Ann Div                               80.00 yen        80.00 yen  
  -Q2 Div           40.00 yen           40.00 yen                   
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T